Schulte Roth & Zabel represented Commodore Capital in the transaction.In connection with its acquisition of AlmataBio, Avalo Therapeutics, Inc. issued a PIPE consisting of preferred stock…
Avalo Therapeutics’ $185 Million PIPE
Schulte Roth & Zabel represented Commodore Capital in the transaction.In connection with its acquisition of AlmataBio, Avalo Therapeutics, Inc. issued a PIPE consisting of preferred stock…